In the last two years, just 25 Global Clinical Trials (GCT) were approved to be conducted in India...Doctors have said the decline in the number of clinical trials is a loss to patients, who are being deprived of cutting edge drugs that clinical trials can offer...The new guidelines have brought clinical research in India to a grinding halt. While the intention of the new guidelines may be well meaning, but at the same time, they are so irrational that all the stakeholders in a clinical research are wary of applying for clinical trials,” said Suneela Thatte, president ICSR.